BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32302946)

  • 21. Connected Speech Deficit as an Early Hallmark of CSF-defined Alzheimer's Disease and Correlation with Cerebral Hypoperfusion Pattern.
    Mazzon G; Ajčević M; Cattaruzza T; Menichelli A; Guerriero M; Capitanio S; Pesavento V; Dore F; Sorbi S; Manganotti P; Marini A
    Curr Alzheimer Res; 2019; 16(6):483-494. PubMed ID: 31057108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EEG evidence of compensatory mechanisms in preclinical Alzheimer's disease.
    Gaubert S; Raimondo F; Houot M; Corsi MC; Naccache L; Diego Sitt J; Hermann B; Oudiette D; Gagliardi G; Habert MO; Dubois B; De Vico Fallani F; Bakardjian H; Epelbaum S;
    Brain; 2019 Jul; 142(7):2096-2112. PubMed ID: 31211359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applied multimodal diagnostics in a case of presenile dementia.
    Schönecker S; Brendel M; Huber M; Vollmar C; Huppertz HJ; Teipel S; Okamura N; Levin J; Rominger A; Danek A
    BMC Neurol; 2016 Aug; 16():131. PubMed ID: 27506761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in the EEG amplitude as a biomarker for early detection of Alzheimer's disease.
    Al-Nuaimi AH; Jammeh E; Lingfen Sun ; Ifeachor E
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():993-996. PubMed ID: 28268491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study.
    Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M
    J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Gut Microbiota to Brain Waves: The Potential of the Microbiome and EEG as Biomarkers for Cognitive Impairment.
    Krothapalli M; Buddendorff L; Yadav H; Schilaty ND; Jain S
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of blood biomarkers for use in point of care diagnosis tool for Alzheimer's disease.
    Jammeh E; Zhao P; Carroll C; Pearson S; Ifeachor E
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2415-2418. PubMed ID: 28268812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurophysiological assessment of Alzheimer's disease individuals by a single electroencephalographic marker.
    Lizio R; Del Percio C; Marzano N; Soricelli A; Yener GG; Başar E; Mundi C; De Rosa S; Triggiani AI; Ferri R; Arnaldi D; Nobili FM; Cordone S; Lopez S; Carducci F; Santi G; Gesualdo L; Rossini PM; Cavedo E; Mauri M; Frisoni GB; Babiloni C
    J Alzheimers Dis; 2016; 49(1):159-77. PubMed ID: 26444753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The controversy over early diagnosis of Alzheimer's disease: A literature review of the advantages and disadvantages].
    Gräßel E; Lauer N
    Z Evid Fortbild Qual Gesundhwes; 2023 Jun; 179():95-105. PubMed ID: 37263875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic Review on Resting-State EEG for Alzheimer's Disease Diagnosis and Progression Assessment.
    Cassani R; Estarellas M; San-Martin R; Fraga FJ; Falk TH
    Dis Markers; 2018; 2018():5174815. PubMed ID: 30405860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EEG microstate complexity for aiding early diagnosis of Alzheimer's disease.
    Tait L; Tamagnini F; Stothart G; Barvas E; Monaldini C; Frusciante R; Volpini M; Guttmann S; Coulthard E; Brown JT; Kazanina N; Goodfellow M
    Sci Rep; 2020 Oct; 10(1):17627. PubMed ID: 33077823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach.
    Begcevic I; Brinc D; Brown M; Martinez-Morillo E; Goldhardt O; Grimmer T; Magdolen V; Batruch I; Diamandis EP
    J Proteomics; 2018 Jun; 182():12-20. PubMed ID: 29684683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.
    Henriques AD; Benedet AL; Camargos EF; Rosa-Neto P; Nóbrega OT
    Exp Gerontol; 2018 Jul; 107():169-177. PubMed ID: 29307736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical sources of resting state EEG rhythms are related to brain hypometabolism in subjects with Alzheimer's disease: an EEG-PET study.
    Babiloni C; Del Percio C; Caroli A; Salvatore E; Nicolai E; Marzano N; Lizio R; Cavedo E; Landau S; Chen K; Jagust W; Reiman E; Tedeschi G; Montella P; De Stefano M; Gesualdo L; Frisoni GB; Soricelli A
    Neurobiol Aging; 2016 Dec; 48():122-134. PubMed ID: 27668356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatio-Temporal Fluctuations of Neural Dynamics in Mild Cognitive Impairment and Alzheimer's Disease.
    Poza J; Gómez C; García M; Tola-Arribas MA; Carreres A; Cano M; Hornero R
    Curr Alzheimer Res; 2017; 14(9):924-936. PubMed ID: 28290246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.
    Mattsson N; Eriksson O; Lindberg O; Schöll M; Lampinen B; Nilsson M; Insel PS; Lautner R; Strandberg O; van Westen D; Zetterberg H; Blennow K; Palmqvist S; Stomrud E; Hansson O
    Neurobiol Aging; 2018 Nov; 71():81-90. PubMed ID: 30107289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early dementia diagnosis, MCI-to-dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis.
    Rossini PM; Miraglia F; Vecchio F
    Alzheimers Dement; 2022 Dec; 18(12):2699-2706. PubMed ID: 35388959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.